Electronic nose breath analysis achieved 80-92% accuracy for detecting lung cancer in patients with suspicious findings. Detection accuracy remained consistent across tumor characteristics, disease ...

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

Inside a mobile lab, Our Lady of the Lake Regional Medical Center is showcasing the robotic technology its surgeons and doctors are using to detect and treat lung cancer.

(Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical validation study ever conducted. This milestone strengthens the ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

SEVEN NEWS. LUNG CANCER REMAINS THE LEADING CAUSE OF CANCER RELATED DEATH IN THE UNITED STATES. AS MEDICAL EXPERT DOCTOR RAMO EXPLAINS, RECENT GUIDELINE CHANGES COULD HELP SAVE THOUSANDS OF LIVES.

All study participants simultaneously underwent NGS using three sample types: (1) BWF, (2) plasma, and (3) tumor tissue collected during bronchoscopy. The full patient set (FPS) included all enrolled ...